Kazia Therapeutics Announces Pricing Of $40M Underwritten Offering Of ADSs And Pre-Funded Warrants

Benzinga Newsdesk www.benzinga.com Neutral 92.7%

Neg 0% Neu 92.7% Pos 0%

https://www.sec.gov/Archives/edgar/data/1075880/000121390026095303/ea0303882-424b5_kazia.htm

Comments

No comments yet. Be the first!